PortfoliosLab logoPortfoliosLab logo
ISIN
US2854091087
CUSIP
285409108
IPO Date
Aug 13, 2010

Highlights

Market Cap
$308.29M
Enterprise Value
$291.31M
EPS (TTM)
$1.16
PE Ratio
30.64
PEG Ratio
0.84
Total Revenue (TTM)
$71.75M
Gross Profit (TTM)
$56.28M
EBITDA (TTM)
$14.10M
Year Range
$17.73 - $40.00
Target Price
$38.00
ROA (TTM)
16.99%
ROE (TTM)
20.55%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

ELMD Performance Chart

Electromed, Inc. (ELMD) is up 22.4% since the beginning of the year. At $36 per share, ELMD is trading 10.9% below its 52-week high of $40. Investors who bought $1,000 worth of ELMD shares 5 years ago would now be looking at an investment worth $3,259.


Loading charts...

S&P 500 Index

Returns By Period

Electromed, Inc. (ELMD) has returned 22.42% so far this year and 74.07% over the past 12 months. Looking at the last ten years, ELMD has achieved an annualized return of 23.08%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.


Electromed, Inc.

1D
-2.54%
1M
39.48%
YTD
22.42%
6M
27.55%
1Y
74.07%
3Y*
44.52%
5Y*
26.65%
10Y*
23.08%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELMD Monthly Returns History

Based on dividend-adjusted daily data since Aug 13, 2010, ELMD's average daily return is +0.14%, while the average monthly return is +3.08%. At this rate, an investment would double in approximately 1.9 years.

Historically, 51% of months were positive and 49% were negative. The best month was Dec 2013 with a return of +208.6%, while the worst month was Jan 2014 at -50.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 11 months.

On a daily basis, ELMD closed higher 46% of trading days. The best single day was Dec 30, 2013 with a return of +106.9%, while the worst single day was Nov 8, 2017 at -18.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20262.58%-20.66%-1.22%9.82%46.71%-5.49%22.42%
202516.41%-21.40%-11.76%-3.48%-12.29%8.86%-17.19%35.80%-0.73%-2.00%11.26%8.78%-1.46%
2024-7.88%51.24%6.25%7.68%-15.93%2.80%4.06%9.65%25.19%8.29%32.39%-4.00%170.85%
20232.86%23.49%-21.95%5.29%6.76%-8.38%-4.76%-2.75%4.74%1.35%-2.37%6.13%4.00%
2022-0.38%-5.33%1.47%1.85%-11.05%-14.46%-6.43%7.54%5.67%3.61%-5.93%5.01%-19.31%
20211.33%6.24%-0.19%-7.31%0.92%14.50%3.99%5.88%-12.95%1.48%9.47%8.15%32.52%

Benchmark Metrics

Electromed, Inc. has an annualized alpha of 29.67%, beta of 0.60, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 16, 2010.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.34%) than losses (51.78%) - typical of diversified or defensive assets.
  • Beta of 0.60 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
29.67%
Beta
0.60
0.02
Upside Capture
74.34%
Downside Capture
51.78%

Return for Risk

Risk / Return Rank

ELMD ranks 80 for risk / return — in the top 80% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


ELMD Risk / Return Rank: 8080
Overall Rank
ELMD Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
ELMD Sortino Ratio Rank: 8080
Sortino Ratio Rank
ELMD Omega Ratio Rank: 7878
Omega Ratio Rank
ELMD Calmar Ratio Rank: 8383
Calmar Ratio Rank
ELMD Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Electromed, Inc. (ELMD) and compare them to S&P 500 Index.


ELMDBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.41

2.24

-0.83

Sortino ratio

Return per unit of downside risk

2.27

3.07

-0.80

Omega ratio

Gain probability vs. loss probability

1.29

1.41

-0.11

Calmar ratio

Return relative to maximum drawdown

3.20

2.93

+0.27

Martin ratio

Return relative to average drawdown

6.48

13.52

-7.04

Dividends

Dividend History


Electromed, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Electromed, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Electromed, Inc. was 78.65%, occurring on Sep 16, 2013. Recovery took 617 trading sessions.

The current Electromed, Inc. drawdown is 9.26%.


Related event

Drawdown

Fall

Recovery

Underwater

2013 bear market2013
-78.65%Sep 2013
1y 10mo2y 5mo
4y 4moOct 2011 - Feb 2016
2020 bear market2020
-55.84%Nov 2020
2mo 24d3y 6mo
3y 8moAug 2020 - May 2024
2025 bear market2025
-48.86%Jul 2025
5mo 22d9mo 27d
1y 3moJan 2025 - May 2026
COVID crash2020
-45.86%Mar 2020
21d27d
1mo 18dFeb 2020 - Apr 2020
2016 bear market2016
-39.72%Nov 2016
2mo 11d7mo 14d
9mo 25dAug 2016 - Jun 2017

Drawdown Indicators


ELMDBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-78.65%

-56.78%

-21.87%

Max Drawdown (1Y)

Largest decline over 1 year

-23.27%

-9.10%

-14.17%

Max Drawdown (3Y)

Largest decline over 3 years

-48.86%

-18.90%

-29.96%

Max Drawdown (5Y)

Largest decline over 5 years

-48.86%

-25.43%

-23.43%

Max Drawdown (10Y)

Largest decline over 10 years

-55.84%

-33.92%

-21.92%

Current Drawdown

Current decline from peak

-9.26%

-0.74%

-8.52%

Average Drawdown

Average peak-to-trough decline

-33.81%

-10.72%

-23.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.47%

1.97%

+9.50%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Electromed, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Electromed, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ELMD, comparing it with other companies in the Medical Devices industry. Currently, ELMD has a P/E ratio of 30.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ELMD compared to other companies in the Medical Devices industry. ELMD currently has a PEG ratio of 0.8. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ELMD relative to other companies in the Medical Devices industry. Currently, ELMD has a P/S ratio of 4.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ELMD in comparison with other companies in the Medical Devices industry. Currently, ELMD has a P/B value of 6.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ELMD

Add Electromed, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ELMD